Correction: Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies

Documenti analoghi

• Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies
  di: Alinezhad, Saeid, et al.
  Pubblicazione: (2016)
• Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.
  di: Saeid Alinezhad, et al.
  Pubblicazione: (2016-01-01)
• Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
  di: Alinezhad, Saeid, et al.
  Pubblicazione: (2016)
• Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates
  di: Väänänen, Riina-Minna, et al.
  Pubblicazione: (2015)
• Targeting the cancer cells and cancer‐associated fibroblasts with next‐generation FGFR inhibitors in prostate cancer co‐culture models
  di: Syeda Afshan, et al.
  Pubblicazione: (2024-09-01)